STEALTH in transplantation tolerance (Immunologic Research (2002) 26, (143-152) DOI: 10.1385/IR:26:1-3:143);STEALTH in transplantation tolerance

Immunologic Research

Volumn 26, Issue 1-3, 2002, Pages 143-152

  Hutchings, Anne ^a   Hubbard, William J ^a   Thomas, Frank T ^a   Thomas, Judith M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Depletion; Immunosuppression; Immunotoxin; Islet; Kidney; Lymphocyte; Nonhuman primate; Transplantation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOTOXIN; PROTEIN; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LYMPHOCYTE DEPLETION; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RECIPIENT; SIGNAL TRANSDUCTION; SURVIVAL TIME; T LYMPHOCYTE; TRANSPLANTATION;

EID: 0036394289     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-007-8007-8     Document Type: Erratum

References (53)

1. Cecka JM: The UNOS Scientific Renal Transplant Registry-2000. Clin Transpl 2000;14:1-18.
2. Li XC, Wells AD, Strom TB, Turka LA: The role of T cell apoptosis in transplantation tolerance. Curr Opin Immunol 2000;12:522-527.
3. Waldmann PH, Cobbold S: T-cell regulation and transplantation tolerance. Curr Opin Organ Transplant 2000;5:83-89.
4. Salama AD, Remuzzi G, Harmon WE, Sayegh MH: Challenges to achieving clinical transplantation tolerance. J Clin Invest 2001;108:943-948.
5. Thomas JM, Contreras JL, Jiang XL, Eckhoff DE, Wang PX, Hubbard WJ, et al: Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 1999;68:1660-1673.
6. Thomas JM, Hubbard WJ, Sooudi SK, Thomas FT: STEALTH matters: a novel paradigm of durable primate allograft tolerance. Immunol Rev 2001;183:223-233.
7. Thomas JM, Thomas FT: A pre-clinical view of transplant tolerance and chimerism: tolerance induction by posttransplant lymphoid irradiation and donor bone marrow; in Ilstad S. (ed.): Chimerism and Tolerance. Heidelberg, Germany, Springer Verlag, 1996, pp. 143-158.
8. Kirk AD: Transplantation tolerance: a look at the nonhuman primate literature in the light of modern tolerance theories. Crit Rev Immunol 1999;19:349-388.
9. Sachs DH: Immunologic tolerance to organ transplants. J Gastrointest Surg 1999;3:105-110.
10. Knechtle SJ: Knowledge about transplantation tolerance gained in primates. Curr Opin Immunol 2000;12:552-556.
11. Wekerle T: Transplantation tolerance induced by mixed chimerism. J Heart Lung Transplant 2001;20:816-823.
12. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
13. Matzinger P. The immune system's role in graft loss: theoretic considerations. Transplant Proc 1997;29:11S-12S.
14. Thomas JM, Eckhoff DE, Contreras JL, et al: Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. Transplantation 2000;69:2497-2503.
15. Contreras JL, Wang PX, Eckhoff DE, et al: Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control. Transplantation 1998;65:1159-1169.
16. Wu L, D'Amico A, Winkel KD, Suter M, Lo D, Shortman K: RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity 1998;9:839-847.
17. Neville DM Jr, Scharff J, Hu HZ, et al: A new reagent for the induction of T-cell depletion, anti-CD3-CRM9. J Immunother Emphasis Tumor Immunol 1996;19:85-92.
18. Hubbard WJ, Contreras JL, Eckhoff DE, Thomas FT, Neville DM, Thomas JM: Immunotoxins and tolerance induction in primates. Curr Opin Organ Transplantation 2000;5:29-34.
19. Nooij FJ, Borst JG, Van Meurs GJ, Jonker M, Balner H: Differentiation antigens on rhesus monkey lymphocytes. I. Identification of T cells bearing CD3 and CD8, and of a subset of CD8-bearing cells. Eur J Immunol 1986;16:975-979.
20. Thomas JM, Neville DM, Contreras JL, et al: Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts. Transplantation 1997;64:124-135.
21. Contreras JL, Eckhoff DE, Cartner S, et al: Tolerability and side effects of anti-CD3-immunotoxin in pre-clinical testing in kidney and pancreatic islet transplant recipients. Transplantation 1999;68:215-219.
22. Steinman RM, Inaba K, Turley S, Pierre P, Mellman I: Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum Immunol 1999;60:562-567.
23. Wu J, He J, Sooudi S, et al: Pretreatment of HL60 cells with Deoxyspergualin enhances trail-induced apoptosis independent of caspase 3 activation. Transplant Proc 2001;33:278.
24. Nadler SG, Eversole AC, Tepper MA, Cleaveland JS. Elucidating the mechanism of action of the immunosuppressant 15-deoxyspergualin. Ther Drug Monit 1995;17:700-703.
25. Snapper CM, Zelazowski P, Rosas FR, et al: B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J Immunol 1996;156:183-191.
26. Thomas JM, Contreras JL, Smyth CA, et al: Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes. Diabetes 2001;50:1227-1236.
27. Shapiro AM, Ryan EA, Lakey JR: Clinical islet transplant-state of the art. Transplant Proc 2001;33:3502-3503.
28. Murray J, Sheil AG, Mosley R, Knight P, Dickinson J, Dammin J: Analysis of mechanism of immunosuppressive drugs in renal homotransplantation. Ann Surg 1964;160:449-473.
29. Hubbard WJ, Moore JK, Contreras JL, et al: Phenotypic and functional analysis of T-cell recovery after anti-CD3 immunotoxin treatment for tolerance induction in rhesus macaques. Hum Immunol 2001;62:479-487.
30. Donnenberg AD, Margolick JB, Donnenberg VS: Lymphopoiesis, apoptosis, and immune amnesia. Ann NY Acad Sci 1995;770:213-226.
31. Cho BK, Rao VP, Ge Q, Eisen HN, Chen J: Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med 2000;192:549-556.
32. Goldrath AW, Bogatzki LY, Bevan MJ: Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 2000;192:557-64.
33. Clarke SR, Rudensky AY: Survival and homeostatic proliferation of naive peripheral CD4+ T cells in the absence of self peptide:MHC complexes. J Immunol 2000;165:2458-2464.
34. Murali-Krishna K, Ahmed R: Cutting edge: naive T cells masquerading as memory cells. J Immunol 2000;165:1733-1737.
35. McKenna RM, Takemoto SK, Terasaki PI: Anti-HLA antibodies after solid organ transplantation. Transplantation 2000;69:319-326.
36. Tepper MA, Nadler SG, Esselstyn JM, Sterbenz KG: Deoxyspergualin inhibits kappa light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation. J Immunol 1995;155:2427-2436.
37. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392:245-252.
38. Bretscher PA: A two-step, two-signal model for the primary activation of precursor helper T cells. Proc Natl Acad Sci USA 1999;96:185-190.
39. Ridge JP, Fuchs EJ, Matzinger P: Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996;271:1723-1726.
40. Rengarajan J, Szabo SJ, Glimcher LH: Transcriptional regulation of Th1/Th2 polarization. Immunol Today 2000;21:479-483.
41. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG: NKT cells: facts, functions and fallacies. Immunol Today 2000;21:573-583.
42. Burdin N, Brossay L, Kronenberg M: Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur J Immunol 1999;29:2014-2025.
43. Carnaud C, Lee D, Donnars O, et al: Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 1999;163:4647-4650.
44. Zhai Y, Kupiec-Weglinski JW: What is the role of regulatory T cells in transplantation tolerance? Curr Opin Immunol 1999;11:497-503.
45. Hara M, Kingsley CI, Niimi M, et al: IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001;166:3789-3796.
46. Levings MK, Roncarolo MG: T-regulatory I cells: a novel subset of CD4 T cells with immunoregulatory properties. J Allergy Clin Immunol 2000;106:S109-S112.
47. Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN: Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 2001;31:1122-1131.
48. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG: IFN-alpha and IL-10induce the differentiation of human type 1 T regulatory cells. J Immunol 2001;166:5530-5539.
49. Inaba K, Turley S, Yamaide F, et al: Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998;188:2163-2173.
50. Weih DS, Yilmaz ZB, Weih F: Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J Immunol 2001;167:1909-1919.
51. Dengler TJ, Pober JS: Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J Immunol 2000;164:5146-5155.
52. Geginat J, Sallusto F, Lanzavecchia A: Cytokine-driven proliferation and differentiation of human naive, central memory and effector memory CD4(+) T cells. J Exp Med 2001;194:1711-1719.
53. Womer KL, Lee RS, Madsen JC, Sayegh MH: Tolerance and chronic rejection. Philos Trans R Soc Lond B Biol Sci 2001;356:727-738.